Published in Clin Infect Dis on August 06, 2001
Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey (ATC) | NCT02479503
Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev (2012) 4.07
Toxoplasmosis: A history of clinical observations. Int J Parasitol (2009) 3.39
Aspergillus infections in transplant recipients. Clin Microbiol Rev (2005) 2.82
Cavitary pulmonary disease. Clin Microbiol Rev (2008) 2.31
Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis (2005) 1.51
Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc Am Thorac Soc (2005) 0.96
Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin Infect Dis (2003) 0.94
Inhaled therapeutics for prevention and treatment of pneumonia. Expert Opin Drug Saf (2009) 0.89
Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis. J Clin Microbiol (2010) 0.85
Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome. Scand J Infect Dis (2012) 0.84
Incidence and risk factors for herpes zoster following heart transplantation. Transpl Infect Dis (2013) 0.84
Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts. Immunology (2009) 0.82
Bio-ecological control of perioperative and ITU morbidity. Langenbecks Arch Surg (2003) 0.80
Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function. Sci Rep (2016) 0.79
Frequency of musculoskeletal complications among the patients receiving solid organ transplantation in a tertiary health-care center. Rheumatol Int (2011) 0.78
Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention. Trop Parasitol (2016) 0.78
Surgical Outcome of Cerebral Aneurysm Clipping Treated with Immunosuppressants: Report of 11 Cases and Review of the Literature. Neurol Med Chir (Tokyo) (2017) 0.75
[Anaesthesia for noncardiac surgery in a heart-transplanted patient: a clinical case and review of the literature]. Pan Afr Med J (2016) 0.75
Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation. Pharmacotherapy (2013) 0.75
Fatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the Literature. Case Rep Infect Dis (2015) 0.75
Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients. Pediatr Transplant (2011) 0.75
Concomitant cat scratch disease and squamous cell carcinoma in a cardiac transplant. Infect Dis Rep (2011) 0.75
Fatal Toxoplasma gondii Dissemination in a Heart Transplant Recipient: Description of a Case. Case Rep Transplant (2012) 0.75
Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients. World J Transplant (2016) 0.75
Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J (1985) 20.39
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
A physical map of 30,000 human genes. Science (1998) 12.43
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
A new system for grading recommendations in evidence based guidelines. BMJ (2001) 11.13
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 9.09
Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science (1988) 7.96
Toxoplasmic encephalitis in AIDS. Clin Infect Dis (1992) 7.64
Replication dynamics of the yeast genome. Science (2001) 7.56
A comprehensive genetic map of the mouse genome. Nature (1996) 6.94
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79
The problem of quality of life in medicine. JAMA (1997) 5.90
An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis. J Infect Dis (1980) 5.57
Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37
Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med (1980) 5.23
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (1991) 5.14
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11
Statistical data analysis in the computer age. Science (1991) 4.97
The compromised host and infection. II. Deep fungal infection. J Infect Dis (1969) 4.63
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med (1982) 4.40
Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med (1974) 4.39
AIDS commentary. Toxoplasmic encephalitis. J Infect Dis (1988) 4.14
Toxoplasmosis in pregnancy. Clin Infect Dis (1994) 3.91
Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet (1972) 3.90
Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol (1980) 3.81
In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes. Infect Immun (1971) 3.81
Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant (2006) 3.78
Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J (2005) 3.75
Health literacy and health-related knowledge among persons living with HIV/AIDS. Am J Prev Med (2000) 3.70
Control of carcinogenesis: a possible role for the activated macrophage. Science (1972) 3.69
Management of acute aortic dissections. Ann Thorac Surg (1970) 3.66
Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science (1968) 3.65
Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol (1983) 3.53
Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA (1984) 3.48
The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. Ann Intern Med (1996) 3.35
Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol (1969) 3.29
Divided attention: evidence for coactivation with redundant signals. Cogn Psychol (1982) 3.28
Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics (1980) 3.21
Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol (1989) 3.20
Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect (2006) 3.14
A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun (1972) 3.12
IgM antibodies in acute toxoplasmosis. II. Prevalence and significance in acquired cases. J Lab Clin Med (1968) 3.07
Regulation of o(2) concentration in soybean nodules observed by in situ spectroscopic measurement of leghemoglobin oxygenation. Plant Physiol (1988) 2.99
Genetic studies of the Lac repressor. XV: 4000 single amino acid substitutions and analysis of the resulting phenotypes on the basis of the protein structure. J Mol Biol (1996) 2.98
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med (1996) 2.97
Toxoplasmosis in the compromised host. Ann Intern Med (1976) 2.96
Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (1989) 2.87
False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol (1997) 2.84
Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products. J Immunol (1976) 2.79
Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol (1988) 2.77
Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis (2001) 2.74
Phagocytic and bacterial properties of normal human monocytes. J Clin Invest (1974) 2.65
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Ann Oncol (2010) 2.64
Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol (1981) 2.61
Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis (1971) 2.58
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut (2001) 2.56
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob Agents Chemother (1991) 2.56
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med (1986) 2.55
Toxoplasmosis: the time has come. N Engl J Med (1988) 2.54
A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54
Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi. J Immunol (1986) 2.53
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis (1990) 2.49
A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence. Genome Res (2001) 2.49
Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun (1994) 2.48
The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J Immunol (1990) 2.47
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation (1997) 2.46
The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii. J Immunol (1972) 2.46
Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis (1993) 2.45
Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol (1972) 2.44
Detection and characterization of membrane antigens of Toxoplasma gondii. J Immunol (1980) 2.43
Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg (1975) 2.43
The cardiac donor. Surg Gynecol Obstet (1971) 2.39
Infectious complications after cardiac transplantation in man. Ann Intern Med (1971) 2.37
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Ann Intern Med (1999) 2.36
Prolonged expiratory apnoea: a disorder resulting in episodes of severe arterial hypoxaemia in infants and young children. Lancet (1985) 2.36
IgM antibodies in acute toxoplasmosis. I. Diagnostic significance in congenital cases and a method for their rapid demonstration. Pediatrics (1968) 2.36
Diffusion tensor imaging of normal and injured developing human brain - a technical review. NMR Biomed (2002) 2.36
Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J Infect Dis (1971) 2.34
Strength of the cement-bone interface. Clin Orthop Relat Res (1982) 2.31
Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation (1974) 2.28
Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature (1985) 2.27
Effect of murine interferon gamma on murine toxoplasmosis. J Infect Dis (1984) 2.27
Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg (1982) 2.26
Overview of the MHC fine mapping data. Diabetes Obes Metab (2009) 2.24
Comparison of laparoscopic and open ventral herniorrhaphy. Am Surg (1999) 2.23
Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation (1998) 2.21
A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20
Antigenemia in recently acquired acute toxoplasmosis. J Infect Dis (1980) 2.20
Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol (1990) 2.19
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS (2001) 2.17
Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy. Br Med J (1968) 2.17
Dead crow densities and human cases of West Nile virus, New York State, 2000. Emerg Infect Dis (2001) 2.17
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrob Agents Chemother (1988) 2.16